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Abstract
Background:  Intra-arterial  injection  of  medications  may  cause  acute  and  severe  ischemia  and
result in  morbidity  and  mortality.  There  is  no  information  in  the  literature  evaluating  the  arte-
rial endothelial  effects  of  sugammadex  and  dexmedetomidine.  The  hypothesis  of  our  study  is
that sugammadex  and  dexmedetomidine  will  cause  histological  changes  in  arterial  endothelial
structure  when  administered  intra-arterially.
Methods:  Rabbits  were  randomly  divided  into  4  groups.  Group  Control  (n  =  7);  no  interven-
tion performed.  Group  Catheter  (n  =  7);  a  cannula  inserted  in  the  central  artery  of  the  ear,  no
medication  was  administered.  Group  Sugammadex  (n  =  7);  rabbits  were  given  4  mg/kg  sugam-
madex into  the  central  artery  of  the  ear,  and  Group  Dexmedetomidine  (n  =  7);  rabbits  were
given 1  g/kg  dexmedetomidine  into  the  central  artery  of  the  ear.  After  72  h,  the  ears  were
amputated  and  histologically  investigated.
Results:  There  was  no  signiﬁcant  difference  found  between  the  control  and  catheter  groups
in histological  scores.  The  endothelial  damage,  elastic  membrane  and  elastic  ﬁber  damage,
smooth  muscle  hypertrophy  and  connective  tissue  increase  scores  in  the  dexmedetomidine
and sugammadex  groups  were  signiﬁcantly  higher  than  both  the  control  and  the  catheter
groups (p  <  0.05).  There  was  no  signiﬁcant  difference  found  between  the  dexmedetomidine
and sugammadex  groups  in  histological  scores.
Conclusion:  Administration  of  sugammadex  and  dexmedetomidine  to  rabbits  by  intra-arterial
routes caused  histological  arterial  damage.  To  understand  the  histological  changes  caused  bytomidine  more  clearly,  more  experimental  research  is  needed.
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Avaliac¸ão  dos  efeitos  de  sugamadex  e  dexmedetomidina  intra-arterial:  estudo
experimental
Resumo
Justiﬁcativa:  A  injec¸ão  intra-arterial  de  medicamentos  pode  causar  isquemia  aguda  e  grave  e
resultar em  morbidade  e  mortalidade.  Não  há  informac¸ões  na  literatura  avaliando  os  efeitos
endoteliais  arteriais  de  sugamadex  e  dexmedetomidina.  A  hipótese  de  nosso  estudo  foi  que
dexmedetomidina  e  sugamadex  causariam  alterac¸ões  histológicas  na  estrutura  endotelial  arte-
rial quando  administrados  por  via  intra-arterial.
Método:  Os  coelhos  foram  randomicamente  divididos  em  quatro  grupos:  grupo  controle  (n  =  7),
sem intervenc¸ão  realizada;  grupo  cateter  (n  =  7),  uma  cânula  foi  inserida  na  artéria  central  da
orelha e  medicamentos  não  foram  administrados;  grupo  sugamadex  (n  =  7),  os  coelhos  rece-
beram 4  mg/kg  de  sugamadex  na  artéria  central  da  orelha;  grupo  dexmedetomidina  (n  =  7),  os
coelhos receberam  1  g/kg  de  dexmedetomidina  na  artéria  central  da  orelha.  Após  72  horas,
as orelhas  foram  amputadas  e  histologicamente  examinadas.
Resultados:  Não  houve  diferenc¸a  signiﬁcativa  entre  os  grupos  controle  e  cateter  referente  aos
escores histológicos.  Os  escores  do  dano  causado  ao  endotélio  e  à  membrana  e  ﬁbra  elásticas,
da hipertroﬁa  do  músculo  liso  e  do  aumento  do  tecido  conjuntivo  foram  signiﬁcativamente
maiores nos  grupos  dexmedetomidina  e  sugamadex  que  em  ambos  os  grupos  controle  e  cateter
(p <  0,05).  Não  houve  diferenc¸a  signiﬁcativa  entre  os  grupos  dexmedetomidina  e  sugamadex  nos
escores histológicos.
Conclusão:  A  administrac¸ão  de  sugamadex  e  dexmedetomidina  a  coelhos  por  via  intra-arterial
causou danos  arteriais  histológicos.  Para  entender  as  alterac¸ões  histológicas  causadas  por  suga-
madex e  dexmedetomidina  com  mais  clareza,  estudos  experimentais  adicionais  são  necessários.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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3  kg.  The  subjects  obtained  from  DEUMF  Experimental  Ani-Introduction
Intra-arterial  injection  of  medications  may  cause  acute
and  severe  ischemia  and  result  in  morbidity  and  mortal-
ity.  The  intra-arterial  injection  and  cannulation  incidence
varies  from  1/3440  to  1/56,000.  Medications  for  sedation
or  general  anesthesia,  mainly,  are  mistakenly  administered
intra-arterially.1,2 Intra-arterial  injection  of  medications
may  cause  acute  and  severe  ischemia.  It  is  difﬁcult  to  fully
determine  the  correct  incidence  of  rare  situations  such
as  this.1--3 After  the  intravenous  forms  of  medications  are
given  through  intra-arterial  routes,  local  ischemia  and  later
tissue  necrosis  may  develop  in  the  artery.  The  physiopatho-
logical  mechanisms  of  intra-arterial  medication  injection
and  development  of  ischemia  are  not  clear.  Among  mech-
anisms  blamed  are  formation  of  crystals  of  medication  in
small  arteries,  secondary  hemolysis  and  platelet  aggrega-
tion  after  intimal  damage,  and  stasis,  thrombosis  and  direct
cytotoxicity  in  the  artery.  The  tissue  damage  is  essentially
determined  by  the  chemical  structure  and  amount  of  the
medication.1--3
The  pathogenesis  of  formation  of  necrosis  after  intra-
arterial  injection  of  medication  is  not  clear.1,4 The  rabbit  ear
model  is  a  frequently  used  method  to  research  the  pathologi-
cal  process  of  intra-arterial  injections.  No  matter  how  visibly
different  rabbit  and  human  ears  are,  they  are  helpful  to
observe  the  tissue  response  to  intra-arterial  medications.4Sugammadex  is  a  medication  newly  entering  anesthesia
practice.  It  is  a  cyclodextrine-structured  medication  that
selectively  binds  to  aminosteroid-structure  non-depolarizing
m
w
(uscle  relaxants  like  rocuronium,  ending  their  effects.  It
hows  high  selectivity  especially  for  rocuronium  and  vecuro-
ium.  It  may  enter  physicochemical  reactions  with  different
edications.5
There  is  no  information  in  the  literature  evaluat-
ng  the  arterial  endothelial  effects  of  sugammadex  and
exmedetomidine,  two  medications  newly  entering  anes-
hetic  practice.  Only  a  single  case  report  was  found  about
exmedetomidine  mistakenly  administered  intra-arterially.6
The  hypothesis  of  our  study  is  that  sugammadex  and
exmedetomidine  will  cause  histological  changes  in  arte-
ial  structure  when  administered  intra-arterially.  To  test
his  hypothesis  in  this  planned  study  we  used  rabbit  ear
rteries  to  intra-arterially  inject  4  mg/kg  sugammadex  and
 g/kg  dexmedetomidine  aiming  to  research  the  histologi-
al  effects.
ethod
he  study  was  completed  in  Dokuz  Eylül  Universtiy  Medical
aculty  experimental  animal  laboratory  after  receiving  per-
ission  from  Dokuz  Eylül  University  Medical  Faculty  Animal
xperiments  Ethics  Committee  (Meeting  date:  08.01.2014
-  Decision  number:  115/2013).  The  research  used  28  adult
ale  New  Zealand  white  rabbits  weighing  from  2.5  toals  Laboratory  were  fed  with  standard  rabbit  feed  and
ater.  The  rabbits  were  housed  in  temperature-controlled
22--24 ◦C)  illuminated  rooms  (12:12  h  light/dark)  before  the
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tudy.  During  the  experiment  international  guidelines  were
aintained  for  care  of  laboratory  animals.
Using  sterile  techniques  the  rabbits  in  the  experimen-
al  group  were  given  50  mg/kg  ketamine  intraperitoneally.
s  the  animals  may  have  different  responses  to  the  anes-
hetic  medications,  depth  of  anesthesia  was  determined  by
onitoring  palpebra  or  cornea  reﬂexes.
Our  study  used  the  rabbit  ear  model  described  by  Kin-
onth  and  Sheppard.7 Rabbits  with  sufﬁcient  anesthesia  had
ntra-arterial  intervention  with  a  24  G  cannula.
Rabbits  were  randomly  divided  into  4  groups:
Group  Control  (n  =  7):  rabbits  in  this  group  had  no  inter-
ention  performed.
Group  Catheter  (n  =  7):  rabbits  had  a  cannula  inserted  in
he  central  artery  of  the  ear,  however  no  medication  was
dministered.
Group  Sugammadex  (n  =  7):  rabbits  were  given  4  mg/kg
100  mg/mL)  sugammadex  into  the  central  artery  of  the  ear,
iven  as  bolus  within  10  s  for  a  total  volume  of  2  mL.
Group  Dexmedetomidine  (n  =  7):  rabbits  were  given
 g/kg  (100  g/mL)  dexmedetomidine  into  the  central
rtery  of  the  ear  with  loading  dose  administered  with  an
nfusion  pump  over  10  min  for  a  total  volume  of  2  mL.
After  72  h,  the  rabbits  in  all  groups  were  given
0  mg/kg  ketamine  intraperitoneally  and  after  anesthesia
as  provided,  the  ears  were  amputated  and  histologically
nvestigated.
For  macroscopic  investigation  sections  especially  to  eval-
ate  arterial  cross-section,  samples  were  ﬁxed  in  10%
uffered  formaldehyde  and  then  submerged  in  parafﬁn.
hen  the  prepared  parafﬁn  blocks  were  serially  cut  to
 m  thickness  using  a  rotary  microtome  (Leica  RM  2135,
eica  Instruments,  Nussloch,  Germany).  These  sections  were
tained  with  hematoxylin--eosin  and  Masson’s  trichrome.
valuation  of  histomorphology  of  arterial  tissue
o  investigate  the  images  obtained  from  the  sections,  an
mage  analysis  method  using  a  computer  video  camera  were
sed  (UTHSC  Image  software).  All  sections  were  analyzed,
nly  sections  with  clear  artifacts  linked  to  staining  were
xcluded  from  the  evaluation.  After  staining  was  completed
he  sections  were  investigated  under  a  light  microscope
Olympus  BX-51,  Tokyo,  Japan)  and  images  were  evaluated
fter  uploading  to  a  computer  with  a  high  resolution  camera
Olympus  DP-71,  Japan).  All  sections  were  digitally  photo-
raphed.
Under  the  light  microscope  arterial  tissue  sections  of  the
ubject  group  were  evaluated  for  arterial  endothelial  reg-
larity  and  integrity,  and  regularity  of  the  internal  elastic
embrane  and  underlying  smooth  muscle  and  elastic  ﬁbers.
he  groups  were  scored  semi  quantitatively  for  endothelial
amage,  elastic  membrane  and  elastic  ﬁber  damage,  smooth
uscle  hypertrophy,  and  increase  in  connective  tissue.  The
coring  was  0  =  none,  1  =  very  slight  damage,  2  =  slight  dam-
ge,  3  =  moderate  damage,  and  4  =  severe  damage.8tatistical analysis
tatistical  analysis  was  performed  by  using  the  Statisti-
al  Package  for  the  Social  Sciences  (SPSS)  version  16.0  for
m
g
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indows  (SPSS  Inc.,  Chicago,  IL,  USA).  The  Kolmogorov--
mirnov  test  was  used  to  examine  compatibility  between
easured  variables  and  normal  distribution.  Mann--Whitney
 test  was  used  for  statistical  analysis.  Descriptive  statis-
ics  included  arithmetic  median  (minimum--maximum).  A
-value  <  0.05  was  considered  signiﬁcant.
esults
he  ear  artery  cross-sections  of  a  total  of  28  New  Zealand
ype  white  rabbits  were  evaluated.
After  rabbits  were  given  the  study  medications  intra-
rterially  until  the  end  of  the  72  h  evaluation  period,
acroscopic  ischemia  and  necrosis  ﬁndings  were  not
bserved  in  the  ears  of  any  rabbit  given  sugammadex  and
exmedetomidine.
All  rabbit’s  ears  arterial  tissues  had  investigated  histo-
ogically.
It  was  observed  that  the  arterial  tissue  of  the  con-
rol  group  had  normal  histological  structure.  The  arterial
ndothelium  was  regular  and  there  was  no  disruption  of  the
ndothelial  continuity  observed.  The  internal  elastic  mem-
rane  was  regular  and  there  was  no  irregularity  observed  in
he  organization  of  the  underlying  smooth  muscle  and  elastic
bers  (Figs.  1--3).
The  catheter  group  samples  had  similar  characteristics
o  the  control  group  (Figs.  1--3).
When  the  dexmedetomidine  group  was  evaluated,  com-
ared  to  the  control  group  there  were  clear  areas  of  tissue
amage  observed  in  some  subjects.  Endothelial  irregularity,
isruption  of  the  endothelial  integrity  and  in  place  endothe-
ial  hypertrophy  was  observed.  There  was  irregularity  in  the
nternal  elastic  membrane,  and  disorganization  of  the  regu-
arity  of  underlying  smooth  muscle  and  elastic  ﬁbers.  In  the
unica  media  there  was  smooth  muscle  hypertrophy  iden-
iﬁed.  When  this  group  is  compared  to  the  control  group,
here  was  an  increase  in  connective  tissue  found  (Figs.  1--3).
When  the  samples  from  the  sugammadex  group  are  eval-
ated  and  compared  with  the  control  group,  irregularity
n  the  endothelium  and  disruption  of  the  integrity  of  the
ndothelium  were  observed.  The  sugammadex  groups  were
bserved  to  have  better  preservation  of  the  arterial  tis-
ue  compared  to  the  dexmedetomidine  group.  Endothelial
ypertrophy  was  not  observed.  The  irregularity  of  the  inter-
al  elastic  membrane  and  disorganization  of  underlying
mooth  muscle  and  elastic  ﬁbers  and  increase  in  connec-
ive  tissue  were  observed  to  be  less  compared  with  the
exmedetomidine  group  (Figs.  1--3).
When  the  results  of  the  histological  evaluation  of  the
roups  is  investigated,  there  was  no  signiﬁcant  difference
ound  between  the  control  and  catheter  groups  in  terms  of
cores  for  endothelial  damage,  damage  to  elastic  membrane
nd  elastic  ﬁbers,  smooth  muscle  hypertrophy  and  connec-
ive  tissue  increase  (p  >  0.05).
The  endothelial  damage,  elastic  membrane  and  elastic
ber  damage,  smooth  muscle  hypertrophy  and  connective
issue  increase  scores  in  the  dexmedetomidine  and  sugam-
adex  groups  were  signiﬁcantly  higher  than  both  the  control
roup  (p  <  0.05)  and  the  catheter  group  (p  <  0.05).
There  was  no  signiﬁcant  difference  found  between  the
exmedetomidine  and  sugammadex  groups  in  terms  of
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mFigure  1  Representative  light-microscopic  images  of  H--E  sta
sugammadex  group  (C),  and  dexmedetomidine  group  (D).  (  )  
damage.
scores  for  endothelial  damage,  elastic  membrane  and  elastic
ﬁber  damage,  smooth  muscle  hypertrophy  and  connective
tissue  increase  (p  >  0.05).  The  results  of  the  histological
evaluation  of  the  groups  can  be  seen  in  Table  1.Discussion
This  study  aimed  to  research  the  histological  effects
of  4  mg/kg  sugammadex  and  1  g/kg  dexmedetomidine
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Table  1  Histological  evaluation  of  the  study  groups  [median  (min
Groups  Endothelial
damage
Dama
mem
elast
Group  Control  (n  =  7)  0.0  (0.0--0.0)  0.0  (
Group Catheter  (n  =  7)  0.0  (0.0--1.0)  0.0  (
Group Dexmedetomidine  (n  =  7)  2.0  (2.0--3.0)a,b 2.0  (
Group  Sugammadex  (n  =  7)  2.0  (1.0--2.0)a,b 2.0  (
a p < 0.05, in comparison with Group Control, Mann--Whitney U test.
b p < 0.05, in comparison with Group Catheter, Mann--Whitney U test. in  vascular  tissue  in  the  control  group  (A),  catheter  group  (B),
ate  smooth  muscle  hypertrophy  and  (  )  indicate  endothelial
dministered  intra-arterially  using  rabbit  ear  arteries.  After
he  administration  of  dexmedetomidine  and  sugammadex  it
as  observed  that  scores  for  histological;  endothelial  dam-
ge,  elastic  membrane  and  elastic  ﬁber  damage,  smooth
uscle  hypertrophy  and  increase  in  connective  tissue  wereigniﬁcantly  higher  compared  with  control  and  catheter
roups.  Additionally  in  no  rabbit  was  tissue  ischemia  and
issue  necrosis  observed  after  intra-arterial  administration
f  dexmedetomidine  and  sugammadex.
imum--maximum)].
ge  to  elastic
brane  and
ic  ﬁbers
Smooth
muscle
hypertrophy
Connective
tissue
increase
0.0--1.0)  0.0  (0.0--1.0)  0.0  (0.0--0.0)
0.0--1.0)  0.0  (0.0--0.0)  0.0  (0.0--1.0)
2.0--3.0)a,b 2.0  (2.0--3.0)a,b 2.0  (1.0--3.0)a,b
1.0--2.0)a,b 2.0  (1.0--2.0)a,b 2.0  (1.0--2.0)a,b
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Figure  2  Representative  light-microscopic  images  of  H--E  staining  (A1--B1--C1  40×  and  A2--B2--C2  100×  magniﬁcation)  in  vascular
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oissue in  the  dexmedetomidine  group.  (  )  indicate  smooth  
nterna, and  (  )  indicate  endothelial  hypertrophy.
As  a  result  of  mistaken  administration  of  medications
ntra-arterially,  serious  complications  such  as  endothelial
estruction,  tissue  necrosis,  thrombosis  and  loss  of  extrem-
ties  may  occur.1,2,9,10 The  majority  of  cases  of  medication
istakenly  administered  intra-arterially  involve  agents  used
or  anesthesia  and  sedation.1,2 Various  studies  have  reported
he  incidence  of  iatrogenic  intra-arterial  cannula  inser-
ion  and  intra-arterial  medication  administration  as  having
ates  between  1/56,000  and  1/3440.2,10 Studies  by  D’Eramo
t  al.11 reported  this  rate  as  2/57,575.  However  it  is  difﬁ-
ult  to  determine  the  correct  incidence  of  situations  that  are
P
b
p
ale  hypertrophy,  (  )  indicate  disorder  in  membrane  elastica
are,  like  this  one.1,10 When  confronted  with  this  unwanted
ituation  though  it  is  reported  that  early  intervention  is  of
reat  importance,  there  are  no  well-described  treatment
ethods  for  patients.12,13
Following  intra-arterial  injection,  discomfort,  local
rritation  and  intense  pain  distal  from  the  injection  site  are
bserved  as  the  ﬁrst  symptoms  frequently  within  seconds.
ain  may  be  described  as  similar  to  an  electric  shock  or  a
urning  sensation  in  the  ﬁngertips.  A  short  time  later,  the
atient  may  describe  sensory  problems  like  tingling,  burning
nd  numbness.  Changes  in  motor  functions  like  involuntary
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aFigure  3  Representative  light-microscopic  images  of  Masson
catheter group  (B),  sugammadex  group  (C),  and  dexmedetomid
muscle  spasms  and  muscle  weakness  and  skin  ﬁndings  of
redness  and  skin  rashes  may  be  encountered.1,2,10,14
Ghouri  et  al.10 reported  the  signs  that  may  cause  intra-
arterial  cannulization  to  be  considered  as  bright  red  blood
coming  from  the  cannula,  pulsatile  movement  of  the  can-
nula,  blood  ﬂows  back  into  the  serum  set  even  though  the
junction  of  ﬂuid  and  cannula  is  higher,  cannulas  in  high  risk
areas  where  arteries  and  veins  are  close  such  as  the  ante-
cubital  region,  and  pressure  increase  in  arterial  catheter
p
i
lichrome  staining  in  vascular  tissue  in  the  control  group  (A),
roup  (D)  (  )  indicate  increase  in  connective  tissue.
reviously  inserted  in  the  same  extremity.  However  in  our
ase  of  intra-arterial  pheniramine  injection,  diagnosis  was
nly  possible  after  blood  gas  analysis,  and  if  intra-arterial
dministration  is  suspected  conﬁrmation  tests  of  blood  gas
nalysis  or  intra  vein  pressure  measurements  should  be
1erformed.
The  most  important  stage  of  treatment  for  intra-arterial
njection  is  to  provide  anticoagulation  with  heparin  and
ocal  thrombolytics  as  quickly  as  possible  to  patients
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industries  to  transform  lipophobic  agents  into  lipophilic62  
ithout  contraindications.15 An  important  part  of  treatment
s  formed  by  preventing  vasospasm  in  the  artery.  Intra-
rterial  administration  of  local  anesthetics  like  procaine
nd  lidocaine  and  vasodilatators  like  papaverine  are  aimed
t  preventing  vasospasm.1,2,10,15 Peripheral  nerve  block
dministration  is  an  interventional  treatment  method  for
ntra-arterial  injections  aiming  to  reduce  or  prevent  reﬂex
asospasm  and  lengthened  vasoconstriction  by  providing
ympathetic  blockage.  This  intervention  may  reduce  pain,
rovide  perfusion  and  reduce  vasospasm  and  efﬁciently
chieves  therapeutic  aims.  Continuous  administration  with
he  aid  of  a  catheter  increases  the  beneﬁts  of  the  tech-
ique.  However  peripheral  nerve  blocks  may  not  be  the  ﬁrst
hoice  of  intervention  for  some  patients  due  to  the  associ-
ted  risks.1,2,10,15
As  case-controlled  human  studies  of  intra-arterial  med-
cation  injections  cannot  be  performed,  there  are  very
ew  publications  about  treatment  presenting  experimental
tudies  and  treatment  algorithms.16--18 Using  the  rabbit  ear
odel  is  a  good  alternative  to  research  the  pathological  pro-
ess  of  intra-arterial  injection.  Knill  and  Evans4 researched
he  intra-arterial  effects  of  thiopental,  chlorpromazine  and
mphetamine  using  the  rabbit  ear  model  and  found  that
edication  doses  causing  gangrene  in  humans  had  the  same
ffect  on  rabbit  ears.  As  a  result  we  chose  to  use  the  rabbit
ar  model  in  this  study.
Though  the  clinical  tableau  of  intra-arterial  injections  is
ell  described,  the  underlying  physiopathological  mecha-
isms  are  not  clear.  Studies  have  mentioned  mechanisms
uch  as  norepinephrine-moderated  vasoconstriction,  cre-
tion  of  platelet  aggregation  and  intra-arterial  thrombus
inked  to  medication  or  cannula,  endothelial  inﬂamma-
ion,  direct  cytotoxic  effects,  liphophilic  characteristics
f  the  medication  and  osmolarity  characteristics  of  the
edication.1,2,10,15 The  common  result  of  these  studies  is
hat  all  medications  do  not  cause  ischemia  by  the  same
athway,  that  the  last  common  point  in  the  pathogenesis
f  all  intra-arterial  injections  independent  of  the  variety
f  mechanisms  is  thrombosis  and  as  it  is  not  suitable  for
road  prospective  human  studies,  clear  understanding  of
he  pathogenesis  is  necessary  for  development  of  correct
reatment  models.1,2,10,15
In  the  literature  there  are  many  cases  reported  of  seri-
us  complications  observed  after  intra-arterial  medication
njection.  It  is  reported  that  as  a  result  of  iatrogenic  admin-
stration  of  local  anesthetic  agent  through  intra-arterial
outes,  rhabdomyolysis  occurred.19 In  the  benzodiazepin
roup,  after  diazempam  and  temazepam,  fasciotomy  and
mputation  were  performed  due  to  the  occurrence  of
hlebitis,  vascular  disorders,  and  arterial  and  venous
hrombosis.20--23 After  phenytoin  was  given  by  arterial  route
schemia,  necrosis  and  death  was  reported,24 while  after
romazine,  promethazine  and  chlorpromazine  from  the  phe-
othiazine  group  necrosis  and  extremity  loss  have  been
eported.25,26 After  thiopenthal,  a  barbiturate,  endoar-
eritis,  vasoconstriction,  thrombosis  and  tissue  necrosis
ccurred.27--30 Similar  results  were  encountered  as  a  result
f  antibiotics  given  by  arterial  route.  There  are  cases  of
ecrosis  and  tissue  loss  found  with  penicilin,  ﬂoxacillin
nd  clindamycin,  frequently  used  in  daily  practice.31--33
lear  ischemic  appearance  and  gangrene  have  been
eported  after  intra-arterial  administration  of  atracurium
t
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nd  tubocurarine,  used  in  anesthesia  as  neuromuscular
lockers.34,35
In  addition  to  these  catastrophic  results,  more  moder-
te  progression  after  intra-arterial  administrations  is  found.
ifferent  results  are  reported  for  different  paracetemol
reparations.  A  7  year  old  case  undergoing  craniotomy  for
edulloblastoma  was  given  350  mg  paracetemol  into  the
adial  artery  by  mistake  during  the  postoperative  period.
he  case  was  monitored  but  asymptomatic  and  on  the
th  day  postoperative  doppler  ultrasonography  revealed
adial  artery  pulsation  was  normal.  However  a  42  year
ld  case  undergoing  laparoscopic  cholecystectomy  was  mis-
akenly  given  900  mg  benzyl  alcohol-based  paracetemol
ntra-arterially  at  the  end  of  surgery  for  postoperative  anal-
esia.  When  the  patient  complained  in  the  recovery  unit  of
ain  in  the  right  hand,  this  pain  was  thought  to  be  possi-
ly  due  to  mistaken  injection  in  the  cannula  inserted  in  the
ight  radial  artery.  Forty  minutes  later  as  a  result  of  notic-
ng  blue  color  changes  in  2  ﬁngers  responding  to  radial  artery
istribution,  treatment  was  begun;  however  in  spite  of  this
he  affected  ﬁngers  had  to  be  amputated.  As  a  result  the
uthors  stated  that  medications  prepared  with  preservatives
ike  water-insoluble  benzyl  alcohol  may  lead  to  endothe-
ial  edema  and  capillary  endothelial  dysfunction  causing
asospasm.36
Intra-arterial  complications  of  water-insoluble  medica-
ions  like  propofol,  etomidate  and  diazepam,24,35--37 and
igh  alkali  medications  like  thiopental  and  phenytoin24,27
ave  been  known  for  years.  Contrary  to  this  there
re  no  unwanted  effects  of  intra-arterial  injection  of
edications  like  atropine,  succinylcholine,  pancuronium,
idazolam  and  fentanyl.24 The  side  effects  of  medica-
ion  like  adenosine,  neostigmine--atropine  combination  and
eostigmine--glycopyrrolate  have  not  been  reported.38,39 It
s  known  that  more  complications  are  caused  by  membrane-
oluble  medications.4
Babacan  et  al.30 in  a  study  researching  the  histopatho-
ogical  criteria  of  intra-arterial  effects  of  thiopental
nd  propofol  in  rabbits  found  that  intra-arterial  admin-
stration  of  2.5%  thiopental  may  be  responsible  for
angrenous  changes  and  though  this  effect  was  not  found
ith  1%  propofol,  they  concluded  it  could  cause  clear
dema.
Though  there  is  much  literature  information  on  the
ntra-arterial  effects  of  many  agents  used  in  anesthe-
ia,  the  studies  on  sugammadex  and  dexmedetomidine
hich  have  newly  entered  clinical  application  are  very
imited.
Sugammadex  is  a  modiﬁed  gamma  cyclodextrin  molecule
hich  has  newly  entered  trade  use.  The  unique  molecu-
ar  structure  of  sugammadex  encapsulates  rocuronium,  a
euromuscular  blocker,  removing  it  from  the  muscle--nerve
unction  and  it  is  used  to  selectively  and  rapidly  reverse
euromuscular  blockage.  Cyclodextrins  are  empty  cut-off
one-shaped  or  ring-shaped  ‘‘donut-like’’  molecules  with
ydrophobic  cavity  and  hydrophilic  outer  structure  contain-
ng  sugar  rings  (d-glucopyranose  units)  in  a 3-dimensional
tructure,  frequently  used  in  food  and  pharmaceuticalypes.  The  negatively  charged  hydroxyl  groups  make  the
olecule  soluble  in  water.  The  carbon  atoms  together
ith  the  contained  alpha  1--4  links  provide  the  lipophilic
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cavity.  Thus  the  water-soluble  molecule  surrounds  a
lipophilic  core.  This  structure  is  of  a  suitable  size  to  encap-
sulate  lipophilic  medications  and  increase  water  solubility.
Non-covalent  thermodynamic  interactions  can  form  inclu-
sion  complexes.  The  cavity  size  is  larger  than  alpha  and  beta
gamma  cyclodextrin  and  is  0.8  mm.  Thermodynamic,  Van
der  Waals,  hydrophobic  interactions,  hydrogen  and  charge
transfer  interactions  contribute  to  the  formation  of  inclusion
complexes  (host--guest  complexes).  The  inclusion  complex  is
an  encapsulated  lipophilic  molecule.  The  sugammadex  vial
contains  injection  water  prepared  with  hydrochloric  acid
and  sodium  hydroxide  to  adjust  pH.5,40
In  our  literature  analysis  we  did  not  encounter  any  clini-
cal  or  experimental  data  related  to  the  intra-arterial  effects
of  sugammadex.  In  our  study,  after  4  mg/kg  intra-arterial
sugammadex  administration,  histological  endothelial  dam-
age,  elastic  membrane  and  elastic  ﬁber  damage,  smooth
muscle  hypertrophy  were  observed.  In  addition,  connective
tissue  scores  were  signiﬁcantly  higher  compared  to  the  con-
trol  and  catheter  groups.
A  selective  -2  adrenoreceptor  agonist,  dexmedetomi-
dine  has  gained  a  place  in  anesthesia  practice  due  to
its  sedative  and  analgesic  effects.  Though  dexmedeto-
midine  has  sedative,  analgesic,  and  anxiolytic  effects,
it  does  not  cause  respiratory  depression.  When  given
as  continuous  IV  infusion  it  provides  predictable  stable
hemodynamics.  Dexmedetomidine  is  widely  used  across
a  variable  spectrum  from  neuroanesthesia,  the  intensive
care  patient  population,  gastrointestinal  endoscopy,  and
conscious  ﬁberoptic  intubation.41,42 We  found  one  case
study  of  intra-arterial  administration  of  dexmedetomidine
in  the  literature.  This  case  study  emphasized  that  after
dexmedetomidine  was  mistakenly  administered  to  the  radial
artery  no  ischemic  complications  were  encountered.6 In
our  study  though  tissue  ischemia  and  tissue  necrosis  were
not  observed  after  intra-arterial  administration  of  1  g/kg
dexmedetomidine  as  infusion  over  10  min  using  rabbit  ear
arteries,  histological  evaluation  observed  endothelial  dam-
age,  elastic  membrane  and  elastic  ﬁber  damage,  smooth
muscle  hypertrophy  and  connective  tissue  increase  scores
were  signiﬁcantly  higher  than  in  the  control  and  catheter
groups.
The  most  important  limitation  of  our  study  is  that  we  only
used  a  single  dose  of  sugammadex  and  dexmedetomidine.
Our  study  was  only  able  to  obtain  ethics  committee  per-
mission  for  single  doses  (4  mg/kg  sugammadex  and  1  g/kg
dexmedetomidine).  To  research  whether  sugammadex  and
dexmedetomidine  cause  vein  damage  related  to  dose,
advanced  studies  with  different  doses  are  required.
In  conclusion,  administration  of  sugammadex  and
dexmedetomidine,  newly  entered  anesthesia  practice  and
with  increasing  popularity,  to  rabbits  by  intra-arterial
routes  caused  histological  arterial  damage.  To  under-
stand  the  histological  changes  caused  by  sugammadex
and  dexmedetomidine  more  clearly,  more  experimental
research  is  needed.Conﬂicts of interest
The  authors  declare  no  conﬂicts  of  interest.
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